Skip to content

BioSig Technologies, Inc. STEX Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$46.69M-1,568%-$424.01M-38,481%-$15.58M-714%-$20.37M-421%-$2.8M+18.0%
$1.49M+7,005%$1.47M+4,797%$1.49M+4,700%$554K+1,031%$21K-73.1%
$25.37M+1,123%$48.82M$842K-44.5%$5.37M+21.2%$2.07M+95.5%
-$10.18M-813%-$3.02M-537%-$5.02M-237%-$1.28M+13.7%-$1.12M+15.1%
-$1.5M-$24.47M
$11.34M$11.34M$11.34M$11.34M
$2.01M$2.01M$2.01M$2.01M
-$1.64M-135%$36.78M+3,677,900%$13.4M$0-100%$4.7M+205%
-$13.46M-475%$9.27M+2,060%$8.23M+652%$0-100%$3.59M+1,486%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does BioSig Technologies, Inc. generate?
BioSig Technologies, Inc. (STEX) generated -$19.5M in operating cash flow over the trailing twelve months.
Where does BioSig Technologies, Inc.'s cash flow data come from?
Every line is extracted from BioSig Technologies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.